COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,741 Articles (22,502 medRxiv, 8,239 bioRxiv)

Most recent first Previous |  Page 1774: Articles 17731-17740  | Next

Neutralization of viruses with European, South African, and United States SARS-CoV-2 variant spike proteins by convalescent sera and BNT162b2 mRNA vaccine-elicited antibodies
Tada, T., Dcosta, B. M., Samanovic-Golden, M., Herati, R. S., Cornelius, A., Mulligan, M. J., Landau, N. R.
10.1101/2021.02.05.430003 — Posted: 2021-02-07
Genomic epidemiology identifies emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States
Washington, N. L., Gangavarapu, K., Zeller, M., Bolze, A., Cirulli, E. T., Schiabor Barrett, K. M., Larsen, B. B., Anderson, C., White, S., Cassens, T., Jacobs, S., Levan, G., Nguyen, J., Ramirez, J. M., Rivera-Garcia, C., Sandoval, E., Wang, X., Wong, D., Spencer, E., Robles-Sikisaka, R., Kurzban, E., Hughes, L. D., Deng, X., Wang, C., Servellita, V., Valentine, H., De Hoff, P., Seaver, P., Sathe, S., Gietzen, K., Sickler, B., Antico, J., Hoon, K., Liu, J., Harding, A., Bakhtar, O., Basler, T., Austin, B., Isaksson, M., Febbo, P., Becker, D., Laurent, M., McDonald, E., Yeo, G. W., Knight, R., Laurent, L. C., de Feo, E., Worobey, M., Chiu, C., Suchard, M. A., Lu, J. T., Lee, W., Andersen, K. G.
10.1101/2021.02.06.21251159 — Posted: 2021-02-07 Discussion: Offsite
Subgenomic RNAs as molecular indicators of asymptomatic SARS-CoV-2 infection
Wong, C. H., Ngan, C. Y., Goldfeder, R. L., Idol, J., Kuhlberg, C., Maurya, R., Kelly, K., Omerza, G., Renzette, N., Abreu, F. D., Li, L., Browne, F. A., Liu, E. T., Wei, C.-L.
10.1101/2021.02.06.430041 — Posted: 2021-02-06
Combination therapy of Tocilizumab and steroid for management of COVID-19 associated cytokine release syndrome: A single center experience from Pune, Western India
Dravid, A., Kashiva, R., Khan, Z., Memon, D., Kodre, A., Potdar, P., Mane, M., Borse, R., Pawar, V., Patil, D., Banerjee, D., Bhoite, K., Pharande, R., Kalyani, S., Raut, P., Bapte, M., Mehta, A., Reddy, M. S., Bhayani, K., Laxmi, S. S., Vishnu, P. D., Srivastava, S., Khandelwal, S., More, S., Shinde, R., Pawar, M., Harshe, A., Kadam, S., Mahajan, U., Joshi, G., Mane, D.
10.1101/2021.02.04.21249959 — Posted: 2021-02-06
Assessing the performance of a serological point-of-care test in measuring detectable antibodies against SARS-CoV-2
Coyle, P. V., El Kahlout, R. A., Dargham, S. R., Chemaitelly, H., Kacem, M. A. B. H., Al-Mawlawi, N. H. A., Gillani, I., Younes, N., Al Kanaani, Z., Al Khal, A., Al Kuwari, E., Jeremijenko, A. M., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul Rahim, H. F., Nasrallah, G. K., Yassine, H. M., Al Kuwari, M. G., Al Romaihi, H. E., Tang, P. M., Bertollini, R., Al-Thani, M. H., Abu-Raddad, L. J.
10.1101/2021.02.04.21251126 — Posted: 2021-02-06
The systemic inflammatory response and clinicopathological characteristics in patients admitted to hospital with COVID-19 infection: Comparison of 2 consecutive cohorts
Maguire, D., McMillan, D.
10.1101/2021.02.04.21250932 — Posted: 2021-02-06
SARS-CoV-2 Worldwide Replication Drives Rapid Rise and Selection of Mutations across the Viral Genome: A Time-Course StudyPotential Challenge for Vaccines and Therapies
Weber, S., Ramirez, C. C. M., Weiser, B., Burger, H., Doerfler, W.
10.1101/2021.02.04.21251111 — Posted: 2021-02-06
Prioritizing allocation of COVID-19 vaccines based on social contacts increases vaccination effectiveness
Chen, J., Hoops, S., Marathe, A., Mortveit, H., Lewis, B., Venkatramanan, S., Haddadan, A., Bhattacharya, P., Adiga, A., Vullikanti, A., Wilson, M., Ehrlich, G., Fenster, M., Eubank, S., Barrett, C., Marathe, M.
10.1101/2021.02.04.21251012 — Posted: 2021-02-06
Symptom Prediction and Mortality Risk Calculation for COVID-19 Using Machine Learning
Jamshidi, E., Asgary, A., Tavakoli, N., Zali, A., Dastan, F., Daaee, A., Badakhshan, M., Esmaily, H., Jamaldini, S. H., Safari, S., Bastanhagh, E., Maher, A., Babajani, A., Mehrazi, M., Sendani Kashi, M. A., Jamshidi, M., Sendani, M. H., Jamal Rahi, S., Mansouri, N.
10.1101/2021.02.04.21251143 — Posted: 2021-02-06
Was R<1 before the English lockdowns? On modelling mechanistic detail, causality and inference about Covid-19
Wood, S. N., Wit, E. C.
10.1101/2021.02.03.21251112 — Posted: 2021-02-06 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).